Skip to main content
. 2005 Mar 16;23(29):3814–3823. doi: 10.1016/j.vaccine.2005.02.026

Fig. 3.

Fig. 3

Biological activity of flexi-IL-12. Ten-fold dilutions of flexi-IL-12 transfection supernatant were plotted against equine IFNγ production to produce an S-shaped curve. In parallel, flexi-IL-12 supernatant was incubated with mouse anti-human IL-12 p40/p70 feline cross-reactive neutralising antibody and mouse anti-protein A non-neutralising antibody.